Pre-order Enquiry
Request Free Sample
Global Type 2 Diabetes Market Research Report 2021
SKU ID : QYR-17222307 | Publishing Date : 20-Jan-2021 | No. of pages : 98
Detailed TOC of Global Type 2 Diabetes Market Research Report 2021
1 Type 2 Diabetes Market Overview1.1 Product Overview and Scope of Type 2 Diabetes
1.2 Type 2 Diabetes Segment by Type
1.2.1 Global Type 2 Diabetes Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Insulins
1.2.3 DPP-4 Inhibitors
1.2.4 GLP-1 Receptor Agonists
1.2.5 SGLT-2 Inhibitors
1.3 Type 2 Diabetes Segment by Application
1.3.1 Type 2 Diabetes Sales Comparison by Application: (2021-2027)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Type 2 Diabetes Market Size Estimates and Forecasts
1.4.1 Global Type 2 Diabetes Revenue 2016-2027
1.4.2 Global Type 2 Diabetes Sales 2016-2027
1.4.3 Type 2 Diabetes Market Size by Region: 2016 Versus 2021 Versus 2027
2 Type 2 Diabetes Market Competition by Manufacturers
2.1 Global Type 2 Diabetes Sales Market Share by Manufacturers (2016-2021)
2.2 Global Type 2 Diabetes Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Type 2 Diabetes Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Type 2 Diabetes Manufacturing Sites, Area Served, Product Type
2.5 Type 2 Diabetes Market Competitive Situation and Trends
2.5.1 Type 2 Diabetes Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Type 2 Diabetes Players Market Share by Revenue
2.5.3 Global Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Type 2 Diabetes Retrospective Market Scenario by Region
3.1 Global Type 2 Diabetes Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Type 2 Diabetes Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Type 2 Diabetes Market Facts & Figures by Country
3.3.1 North America Type 2 Diabetes Sales by Country
3.3.2 North America Type 2 Diabetes Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Type 2 Diabetes Market Facts & Figures by Country
3.4.1 Europe Type 2 Diabetes Sales by Country
3.4.2 Europe Type 2 Diabetes Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Type 2 Diabetes Market Facts & Figures by Region
3.5.1 Asia Pacific Type 2 Diabetes Sales by Region
3.5.2 Asia Pacific Type 2 Diabetes Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Type 2 Diabetes Market Facts & Figures by Country
3.6.1 Latin America Type 2 Diabetes Sales by Country
3.6.2 Latin America Type 2 Diabetes Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Type 2 Diabetes Market Facts & Figures by Country
3.7.1 Middle East and Africa Type 2 Diabetes Sales by Country
3.7.2 Middle East and Africa Type 2 Diabetes Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Type 2 Diabetes Historic Market Analysis by Type
4.1 Global Type 2 Diabetes Sales Market Share by Type (2016-2021)
4.2 Global Type 2 Diabetes Revenue Market Share by Type (2016-2021)
4.3 Global Type 2 Diabetes Price by Type (2016-2021)
5 Global Type 2 Diabetes Historic Market Analysis by Application
5.1 Global Type 2 Diabetes Sales Market Share by Application (2016-2021)
5.2 Global Type 2 Diabetes Revenue Market Share by Application (2016-2021)
5.3 Global Type 2 Diabetes Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novo Nordisk Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Eli Lily
6.4.1 Eli Lily Corporation Information
6.4.2 Eli Lily Description and Business Overview
6.4.3 Eli Lily Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lily Product Portfolio
6.4.5 Eli Lily Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Astellas Pharma Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Daiichi Sankyo
6.6.1 Daiichi Sankyo Corporation Information
6.6.2 Daiichi Sankyo Description and Business Overview
6.6.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Daiichi Sankyo Product Portfolio
6.7.5 Daiichi Sankyo Recent Developments/Updates
6.8 Biocon
6.8.1 Biocon Corporation Information
6.8.2 Biocon Description and Business Overview
6.8.3 Biocon Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biocon Product Portfolio
6.8.5 Biocon Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Boehringer Ingelheim Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
7 Type 2 Diabetes Manufacturing Cost Analysis
7.1 Type 2 Diabetes Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Type 2 Diabetes
7.4 Type 2 Diabetes Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Type 2 Diabetes Distributors List
8.3 Type 2 Diabetes Customers
9 Type 2 Diabetes Market Dynamics
9.1 Type 2 Diabetes Industry Trends
9.2 Type 2 Diabetes Growth Drivers
9.3 Type 2 Diabetes Market Challenges
9.4 Type 2 Diabetes Market Restraints
10 Global Market Forecast
10.1 Type 2 Diabetes Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Type 2 Diabetes by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Type 2 Diabetes by Type (2022-2027)
10.2 Type 2 Diabetes Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Type 2 Diabetes by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Type 2 Diabetes by Application (2022-2027)
10.3 Type 2 Diabetes Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Type 2 Diabetes by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Type 2 Diabetes by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Type 2 Diabetes Market Research Report 2021
List of TablesTable 1. Global Type 2 Diabetes Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Type 2 Diabetes Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Type 2 Diabetes Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Type 2 Diabetes Covered in This Study
Table 5. Global Type 2 Diabetes Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Type 2 Diabetes Sales Share by Manufacturers (2016-2021)
Table 7. Global Type 2 Diabetes Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Type 2 Diabetes Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Type 2 Diabetes Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Type 2 Diabetes Manufacturing Sites and Area Served
Table 11. Manufacturers Type 2 Diabetes Product Type
Table 12. Global Type 2 Diabetes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Type 2 Diabetes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Type 2 Diabetes Sales by Region (2016-2021) & (K MT)
Table 16. Global Type 2 Diabetes Sales Market Share by Region (2016-2021)
Table 17. Global Type 2 Diabetes Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Type 2 Diabetes Sales by Country (2016-2021) & (K MT)
Table 19. North America Type 2 Diabetes Sales Market Share by Country (2016-2021)
Table 20. North America Type 2 Diabetes Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Type 2 Diabetes Revenue Market Share by Country (2016-2021)
Table 22. Europe Type 2 Diabetes Sales by Country (2016-2021) & (K MT)
Table 23. Europe Type 2 Diabetes Sales Market Share by Country (2016-2021)
Table 24. Europe Type 2 Diabetes Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Type 2 Diabetes Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Type 2 Diabetes Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Type 2 Diabetes Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Type 2 Diabetes Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Type 2 Diabetes Revenue Market Share by Region (2016-2021)
Table 30. Latin America Type 2 Diabetes Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Type 2 Diabetes Sales Market Share by Country (2016-2021)
Table 32. Latin America Type 2 Diabetes Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Type 2 Diabetes Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Type 2 Diabetes Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Type 2 Diabetes Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Type 2 Diabetes Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Type 2 Diabetes Revenue Market Share by Country (2016-2021)
Table 38. Global Type 2 Diabetes Sales (K MT) by Type (2016-2021)
Table 39. Global Type 2 Diabetes Sales Market Share by Type (2016-2021)
Table 40. Global Type 2 Diabetes Revenue (Million US$) by Type (2016-2021)
Table 41. Global Type 2 Diabetes Revenue Share by Type (2016-2021)
Table 42. Global Type 2 Diabetes Price (USD/MT) by Type (2016-2021)
Table 43. Global Type 2 Diabetes Sales (K MT) by Application (2016-2021)
Table 44. Global Type 2 Diabetes Sales Market Share by Application (2016-2021)
Table 45. Global Type 2 Diabetes Revenue (Million US$) by Application (2016-2021)
Table 46. Global Type 2 Diabetes Revenue Share by Application (2016-2021)
Table 47. Global Type 2 Diabetes Price (USD/MT) by Application (2016-2021)
Table 48. Novo Nordisk Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novo Nordisk Type 2 Diabetes Product
Table 52. Novo Nordisk Recent Developments/Updates
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Sanofi Type 2 Diabetes Product
Table 57. Sanofi Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Merck Type 2 Diabetes Product
Table 62. Merck Recent Developments/Updates
Table 63. Eli Lily Corporation Information
Table 64. Eli Lily Description and Business Overview
Table 65. Eli Lily Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Eli Lily Type 2 Diabetes Product
Table 67. Eli Lily Recent Developments/Updates
Table 68. AstraZeneca Corporation Information
Table 69. AstraZeneca Description and Business Overview
Table 70. AstraZeneca Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. AstraZeneca Type 2 Diabetes Product
Table 72. AstraZeneca Recent Developments/Updates
Table 73. Astellas Pharma Corporation Information
Table 74. Astellas Pharma Description and Business Overview
Table 75. Astellas Pharma Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Astellas Pharma Type 2 Diabetes Product
Table 77. Astellas Pharma Recent Developments/Updates
Table 78. Daiichi Sankyo Corporation Information
Table 79. Daiichi Sankyo Description and Business Overview
Table 80. Daiichi Sankyo Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Daiichi Sankyo Type 2 Diabetes Product
Table 82. Daiichi Sankyo Recent Developments/Updates
Table 83. Biocon Corporation Information
Table 84. Biocon Description and Business Overview
Table 85. Biocon Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Biocon Type 2 Diabetes Product
Table 87. Biocon Recent Developments/Updates
Table 88. Boehringer Ingelheim Corporation Information
Table 89. Boehringer Ingelheim Description and Business Overview
Table 90. Boehringer Ingelheim Type 2 Diabetes Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Boehringer Ingelheim Type 2 Diabetes Product
Table 92. Boehringer Ingelheim Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Type 2 Diabetes Distributors List
Table 96. Type 2 Diabetes Customers List
Table 97. Type 2 Diabetes Market Trends
Table 98. Type 2 Diabetes Growth Drivers
Table 99. Type 2 Diabetes Market Restraints
Table 100. Global Type 2 Diabetes Sales Forecast by Type (2022-2027) & (K MT)
Table 101. Global Type 2 Diabetes Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Type 2 Diabetes Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Type 2 Diabetes Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Type 2 Diabetes Sales Forecast by Application (2022-2027) & (K MT)
Table 105. Global Type 2 Diabetes Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Type 2 Diabetes Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Type 2 Diabetes Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Type 2 Diabetes Sales Forecast by Region (2022-2027) & (K MT)
Table 109. Global Type 2 Diabetes Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Type 2 Diabetes Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Type 2 Diabetes Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Type 2 Diabetes
Figure 2. Global Type 2 Diabetes Market Share by Type in 2020 & 2027
Figure 3. Insulins Product Picture
Figure 4. DPP-4 Inhibitors Product Picture
Figure 5. GLP-1 Receptor Agonists Product Picture
Figure 6. SGLT-2 Inhibitors Product Picture
Figure 7. Global Type 2 Diabetes Market Share by Application in 2020 & 2027
Figure 8. Drugstore
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Type 2 Diabetes Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Type 2 Diabetes Market Size 2016-2027 (US$ Million)
Figure 13. Global Type 2 Diabetes Sales 2016-2027 (K MT)
Figure 14. Global Type 2 Diabetes Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Type 2 Diabetes Sales Share by Manufacturers in 2020
Figure 16. Global Type 2 Diabetes Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Type 2 Diabetes Players: Market Share by Revenue in 2020
Figure 18. Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Type 2 Diabetes Sales Market Share by Region (2016-2021)
Figure 20. Global Type 2 Diabetes Sales Market Share by Region in 2020
Figure 21. Global Type 2 Diabetes Revenue Market Share by Region (2016-2021)
Figure 22. Global Type 2 Diabetes Revenue Market Share by Region in 2020
Figure 23. U.S. Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Type 2 Diabetes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Type 2 Diabetes by Type (2016-2021)
Figure 48. Sales Market Share of Type 2 Diabetes by Application (2016-2021)
Figure 49. Sales Market Share of Type 2 Diabetes by Application in 2020
Figure 50. Revenue Share of Type 2 Diabetes by Application (2016-2021)
Figure 51. Revenue Share of Type 2 Diabetes by Application in 2020
Figure 52. Manufacturing Cost Structure of Type 2 Diabetes
Figure 53. Manufacturing Process Analysis of Type 2 Diabetes
Figure 54. Type 2 Diabetes Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Keyplayers in Global Type 2 Diabetes Market Research Report 2021
Novo NordiskSanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Request Sample
Request Discount
